Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Leukemia|February 27, 2009
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndromeR Garg, S Faderl, G Garcia-Manero, et al.
Lakartidningen|April 23, 1980
[Treatment of blood diseases in a specialized department]M Beran, B Carlmark, L Ehn, et al.
Cancer Treatment Reports|February 1, 1982
High-dose AMSA and bone marrow rescue in patients with solid tumorsA R Zander, G Spitzer, S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemiasA E Frankel, J A McCubrey, M S Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|September 11, 2009
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionF P S Santos, S Faderl, G Garcia-Manero, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Leukemia|February 27, 2009
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndromeR Garg, S Faderl, G Garcia-Manero, et al.
Lakartidningen|April 23, 1980
[Treatment of blood diseases in a specialized department]M Beran, B Carlmark, L Ehn, et al.
Cancer Treatment Reports|February 1, 1982
High-dose AMSA and bone marrow rescue in patients with solid tumorsA R Zander, G Spitzer, S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemiasA E Frankel, J A McCubrey, M S Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|September 11, 2009
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionF P S Santos, S Faderl, G Garcia-Manero, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Pageof 26